- Home
- ASR vs ASND Comparison
ASR vs ASND Comparison
Compare ASR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASR
- ASND
- Stock Information
- Founded
- ASR 1996
- ASND 2006
- Country
- ASR Mexico
- ASND Denmark
- Employees
- ASR N/A
- ASND N/A
- Industry
- ASR Aerospace
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ASR Consumer Discretionary
- ASND Health Care
- Exchange
- ASR Nasdaq
- ASND Nasdaq
- Market Cap
- ASR 9.7B
- ASND 9.8B
- IPO Year
- ASR 2000
- ASND 2015
- Fundamental
- Price
- ASR $301.24
- ASND $176.90
- Analyst Decision
- ASR Hold
- ASND Strong Buy
- Analyst Count
- ASR 1
- ASND 16
- Target Price
- ASR $310.00
- ASND $218.19
- AVG Volume (30 Days)
- ASR 90.1K
- ASND 411.5K
- Earning Date
- ASR 07-22-2025
- ASND 05-01-2025
- Dividend Yield
- ASR 8.16%
- ASND N/A
- EPS Growth
- ASR 29.82
- ASND N/A
- EPS
- ASR 2.28
- ASND N/A
- Revenue
- ASR $1,599,173,877.00
- ASND $398,509,511.00
- Revenue This Year
- ASR $17.15
- ASND $75.05
- Revenue Next Year
- ASR $9.16
- ASND $78.14
- P/E Ratio
- ASR $13.13
- ASND N/A
- Revenue Growth
- ASR 21.93
- ASND 12.06
- 52 Week Low
- ASR $248.88
- ASND $111.09
- 52 Week High
- ASR $360.00
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- ASR 32.68
- ASND 60.02
- Support Level
- ASR $312.20
- ASND $169.65
- Resistance Level
- ASR $326.79
- ASND $178.62
- Average True Range (ATR)
- ASR 6.17
- ASND 6.77
- MACD
- ASR -3.27
- ASND 0.03
- Stochastic Oscillator
- ASR 0.20
- ASND 82.61
About ASR Grupo Aeroportuario del Sureste S.A. de C.V.
Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.